Skip to main content
FinSpry Logo
FinSpry
CRMD logo
CRMD
(NASDAQ)
CorMedix Inc.
$8.60-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

CorMedix (CRMD) Company Profile

Complete business overview, executive team, trading details, and corporate information.

CorMedix Inc.
CRMD•Nasdaq Stock Market•Healthcare•Biotechnology

About CorMedix

CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States. Its lead product candidate is DefenCath, an antimicrobial catheter lock solution to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure. CorMedix Inc. was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. The company was incorporated in 2006 and is based in Parsippany, New Jersey.

Company Information

SectorHealthcare
IndustryBiotechnology
CEOJoseph Todisco
Founded2006
IPO DateMarch 25, 2010
Employees191
CountryUnited States
Fiscal YearJanuary - December

Stock Details

ExchangeNasdaq Stock Market (NASDAQ)
CurrencyUSD - USD
TypeStock
SubtypeCommon Stock
Share ClassClass A Shares

Contact Information

Websitecormedix.com
Phone908 517 9500
Address
389 Interpace Pkwy, Suite 450 Parsippany, New Jersey 07054 United States

Corporate Identifiers

CIK0001410098
CUSIP21900C308
ISINUS21900C3088
SIC2834

Leadership Team & Key Executives

Joseph Todisco MBA
Chief Executive Officer and Chairman of the Board of Directors
Elizabeth Masson-Hurlburt B.A.
Executive Vice President, Chief Operating Officer and Chief Integration Officer
Kaufman Beth Zelnick Esq.
EVice President, Chief Legal and Compliance Officer and Corporate Secretary
Susan Blum
Executive Vice President and Chief Financial Officer
Beth Steinbrenner
SVice President and Chief Human Resource Officer
Dr. Matthew T. David M.D.
Executive Vice President and Chief Business Officer
Donna Ucci
Senior Vice President and Head of Global Quality
Dr. Tushar Mukherjee
Senior Vice President and Head of Technical Operations
Michael Seckler
Executive Vice President and Chief Commercial Officer
Dr. Peter Sullivan BCOP, Pharm.D.
Senior Vice President of Market Access